Novo Nordisk
NVO
NVO
505 hedge funds and large institutions have $10.7B invested in Novo Nordisk in 2015 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 181 increasing their positions, 179 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 500 → 505 (+5)
1% more repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 179
0.11% less ownership
Funds ownership: 19.06% → 18.96% (-0.11%)
Holders
505
Holding in Top 10
32
Calls
$36.4M
Puts
$8.25M
Top Buyers
| 1 | +$211M | |
| 2 | +$69.5M | |
| 3 | +$40.5M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$35.1M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$32.5M |
Top Sellers
| 1 | -$132M | |
| 2 | -$80.1M | |
| 3 | -$58.8M | |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$50.2M |
| 5 |
Jennison Associates
New York
|
-$35.9M |